SRF Ltd
SRF Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
1 of 3 strong
The short version
Chemicals business expected to grow 15-20% in FY27, with Q1 already achieving 26% growth. SRF Limited expects steady earnings growth, supported by improvements across all overseas locations with margins anticipated to be higher than previously estimated (Page 14).
From SRF Ltd's Q1 FY27 earnings-call transcript · updated 23 Sept 2026.
Revenue & Sales Performance
- Chemicals business expected to grow 15-20% in FY27, with Q1 already achieving 26% growth.
- Positive volume and price trajectory in Specialty Chemicals and core chemical products; H2 expected stronger than H1.
- Refrigerant gas volumes and prices remain robust, supporting continued growth through the year.
- Performance Films segment saw strong Q1 due to reliable supply and some panic buying; margins to normalize but settle higher than last year.
- Fluoropolymer portfolio (PTFE, PVDF, others) to see meaningful volumes starting end of FY27 into FY28-FY29.
- Pharmaceutical chemicals expected to grow gradually, targeting 20-30% revenue share by 2030.
2 more points from SRF Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what SRF Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- INR 520 crore capex committed for electronic grade films, specifically capacitor grade and conductor grade films.
- Capacitor film plant trial runs completed; expecting early-stage revenue in Q3 FY27 and full capacity by Q1/Q2 FY28.
- PVDF plant commissioning planned by end of Q2 FY27.
- Progress on PTFE higher grades with small capex underway, on track.
- Chemours fluoropolymer project slightly delayed (3-4 months) due to design changes; full capacity expected by 2028-29.
- Focus on expanding aluminum foil exports and higher-grade foil applications (e.g., aseptic packaging); no immediate capacity expansion planned but site at Jetapur has space for future growth.
2 more points from SRF Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what SRF Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from SRF Ltd's call on order book
Pro opens every point from 15K+ earnings calls
SRF Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹4.6K Cr, net profit ₹582 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What SRF Ltd's management said in earlier quarters
Arthneeti Pro · Annual
SRF Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were SRF Ltd Q1 FY27 results?
Chemicals business expected to grow 15-20% in FY27, with Q1 already achieving 26% growth. SRF Limited expects steady earnings growth, supported by improvements across all overseas locations with margins anticipated to be higher than previously estimated (Page 14).
What is SRF Ltd share price analysis?
SRF Ltd currently shows a below-average growth signal. The stock trades at a P/E of 33.2 with a market cap of ₹74,462 Cr. Investors should review the full earnings analysis for detailed insights.
Is SRF Ltd planning capital expenditure?
INR 520 crore capex committed for electronic grade films, specifically capacitor grade and conductor grade films.
Keep SRF Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.